SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001854270-22-000019
Filing Date
2022-08-15
Accepted
2022-08-15 16:26:33
Documents
86
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snti-20220630.htm   iXBRL 10-Q 2346858
2 EX-10.3 a6302210qex103.htm EX-10.3 772263
3 EX-10.4 a6302210qex104.htm EX-10.4 697099
4 CERTIFICATION senti06302210qex311v2.htm EX-31.1 10912
5 CERTIFICATION senti06302210qex312v2.htm EX-31.2 10914
6 CERTIFICATION senti06302210qex321v2.htm EX-32.1 5705
7 CERTIFICATION senti06302210qex322v2.htm EX-32.2 5722
  Complete submission text file 0001854270-22-000019.txt   10529969

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20220630.xsd EX-101.SCH 65553
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snti-20220630_cal.xml EX-101.CAL 59936
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snti-20220630_def.xml EX-101.DEF 347998
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20220630_lab.xml EX-101.LAB 695893
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20220630_pre.xml EX-101.PRE 504827
80 EXTRACTED XBRL INSTANCE DOCUMENT snti-20220630_htm.xml XML 1302416
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40440 | Film No.: 221165998
SIC: 2836 Biological Products, (No Diagnostic Substances)